| | |
Prevalence of Microangiopathy
| |
|---|
|
Variables
|
Groups
|
Duration (0-10 years)
|
p
|
Duration (11-20 years)
|
p
|
Duration (> 20 years)
|
p
|
|---|
|
Overall
| | | | | | | |
|
Retinopathy
|
MS Absent
|
48 (28.2)
|
< 0.0001
|
25 (34.7)
|
0.013
|
6 (46.2)
|
1.000
|
| |
MS Present
|
122 (71.8)
| |
47 (65.3)
| |
7 (53.8)
| |
|
Nephropathy
|
MS Absent
|
61 (29.6)
|
< 0.0001
|
12 (22.6)
|
< 0.0001
|
3 (60.0)
|
1.000
|
| |
MS Present
|
145 (70.4)
| |
41 (77.4)
| |
2 (40.0)
| |
|
Neuropathy
|
MS Absent
|
38 (19.9)
|
< 0.0001
|
18 (31.0)
|
0.005
|
7 (46.7)
|
1.000
|
| |
MS Present
|
153 (80.1)
| |
40 (69.0)
| |
8 (53.3)
| |
|
Men
| | | | | | | |
|
Retinopathy
|
MS Absent
|
36 (34.3)
|
0.002
|
19 (43.2)
|
0.451
|
6 (66.7)
|
0.508
|
| |
MS Present
|
69 (65.7)
| |
25 (56.8)
| |
3 (33.3)
| |
|
Nephropathy
|
MS Absent
|
46 (43.4)
|
0.206
|
11 (36.7)
|
0.200
|
3 (60.0)
|
1.000
|
| |
MS Present
|
60 (56.6)
| |
19 (63.3)
| |
2 (40.0)
| |
|
Neuropathy
|
MS Absent
|
24 (24.2)
|
< 0.0001
|
16 (40.0)
|
0.268
|
6 (60.0)
|
0.754
|
| |
MS Present
|
75 (75.8)
| |
24 (60.0)
| |
4 (40.0)
| |
|
Women
| | | | | | | |
|
Retinopathy
|
MS Absent
|
12 (18.5)
|
< 0.0001
|
6 (21.4)
|
0.004
|
0 (0.0)
|
0.125
|
| |
MS Present
|
53 (81.5)
| |
22 (78.6)
| |
4 (100.0)
| |
|
Nephropathy
|
MS Absent
|
15 (15.0)
|
< 0.0001
|
1 (4.3)
|
< 0.0001
|
0 (0.0)
|
NA
|
| |
MS Present
|
85 (85.0)
| |
22 (95.7)
| |
0 (0.0)
| |
|
Neuropathy
|
MS Absent
|
14 (15.2)
|
< 0.0001
|
2 (11.1)
|
0.001
|
1 (20.0)
|
0.375
|
| |
MS Present
|
78 (84.8)
| |
16 (88.9)
| |
4 (80.0)
| |
